Hall KT - Search Results

1

Catechol-O-methyltransferase association with hemoglobin A1c.

Hall KT, Jablonski KA, Chen L, Harden M, Tolkin BR, Kaptchuk TJ, Bray GA, Ridker PM, Florez JC; Diabetes Prevention Program Research Group; Mukamal KJ, Chasman DI. Hall KT, et al. Metabolism. 2016 Jul;65(7):961-967. doi: 10.1016/j.metabol.2016.04.001. Epub 2016 Apr 14. Metabolism. 2016. PMID: 27282867 Free PMC article.

2

Catechol-O-methyltransferase val158met polymorphism predicts placebo effect in irritable bowel syndrome.

Hall KT, Lembo AJ, Kirsch I, Ziogas DC, Douaiher J, Jensen KB, Conboy LA, Kelley JM, Kokkotou E, Kaptchuk TJ. Hall KT, et al. PLoS One. 2012;7(10):e48135. doi: 10.1371/journal.pone.0048135. Epub 2012 Oct 23. PLoS One. 2012. PMID: 23110189 Free PMC article.

3

Genetic biomarkers of placebo response: what could it mean for future trial design?

Hall KT, Kaptchuk TJ. Hall KT, et al. Clin Investig (Lond). 2013 Apr 1;3(4):311-314. doi: 10.4155/cli.13.8. Clin Investig (Lond). 2013. PMID: 24049631 Free PMC article. No abstract available.

4

Polymorphisms in catechol-O-methyltransferase modify treatment effects of aspirin on risk of cardiovascular disease.

Hall KT, Nelson CP, Davis RB, Buring JE, Kirsch I, Mittleman MA, Loscalzo J, Samani NJ, Ridker PM, Kaptchuk TJ, Chasman DI. Hall KT, et al. Arterioscler Thromb Vasc Biol. 2014 Sep;34(9):2160-7. doi: 10.1161/ATVBAHA.114.303845. Epub 2014 Jul 17. Arterioscler Thromb Vasc Biol. 2014. PMID: 25035343 Free PMC article.

5

Conscientiousness is modified by genetic variation in catechol-O-methyltransferase to reduce symptom complaints in IBS patients.

Hall KT, Tolkin BR, Chinn GM, Kirsch I, Kelley JM, Lembo AJ, Kaptchuk TJ, Kokkotou E, Davis RB, Conboy LA. Hall KT, et al. Brain Behav. 2015 Jan;5(1):39-44. doi: 10.1002/brb3.294. Epub 2014 Nov 13. Brain Behav. 2015. PMID: 25722948 Free PMC article. Clinical Trial.

6

Genetics and the placebo effect: the placebome.

Hall KT, Loscalzo J, Kaptchuk TJ. Hall KT, et al. Trends Mol Med. 2015 May;21(5):285-94. doi: 10.1016/j.molmed.2015.02.009. Epub 2015 Apr 14. Trends Mol Med. 2015. PMID: 25883069 Free PMC article. Review.

7

Genetic variation in catechol-O-methyltransferase modifies effects of clonidine treatment in chronic fatigue syndrome.

Hall KT, Kossowsky J, Oberlander TF, Kaptchuk TJ, Saul JP, Wyller VB, Fagermoen E, Sulheim D, Gjerstad J, Winger A, Mukamal KJ. Hall KT, et al. Pharmacogenomics J. 2016 Oct;16(5):454-60. doi: 10.1038/tpj.2016.53. Epub 2016 Jul 26. Pharmacogenomics J. 2016. PMID: 27457818 Free PMC article. Clinical Trial.

8

Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial.

Ballou S, Kaptchuk TJ, Hirsch W, Nee J, Iturrino J, Hall KT, Kelley JM, Cheng V, Kirsch I, Jacobson E, Conboy L, Lembo A, Davis RB. Ballou S, et al. Among authors: hall kt. Trials. 2017 May 25;18(1):234. doi: 10.1186/s13063-017-1964-x. Trials. 2017. PMID: 28545508 Free PMC article. Clinical Trial.

9

Network analysis of the genomic basis of the placebo effect.

Wang RS, Hall KT, Giulianini F, Passow D, Kaptchuk TJ, Loscalzo J. Wang RS, et al. Among authors: hall kt. JCI Insight. 2017 Jun 2;2(11):e93911. doi: 10.1172/jci.insight.93911. eCollection 2017 Jun 2. JCI Insight. 2017. PMID: 28570268 Free PMC article.

10

Dopaminergic tone does not influence pain levels during placebo interventions in patients with chronic neuropathic pain.

Skyt I, Moslemi K, Baastrup C, Grosen K, Benedetti F, Petersen GL, Price DD, Hall KT, Kaptchuk TJ, Svensson P, Jensen TS, Vase L. Skyt I, et al. Among authors: hall kt. Pain. 2018 Feb;159(2):261-272. doi: 10.1097/j.pain.0000000000001089. Pain. 2018. PMID: 29068872

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

73 results

Search Page